Rosetta Capital


Rosetta Capital is a UK-based venture capital firm specializing in the life sciences and medical device sectors. With a global investment approach, the firm focuses on building leading healthcare companies and breakthrough technologies that enhance human lives. Rosetta Capital primarily invests through direct secondary transactions, providing flexible liquidity solutions to investors and corporations. Over its 20+ year history, the firm has made over 50 venture investments, demonstrating extensive expertise in executing complex transactions efficiently.


Services

Funding

Rosetta Capital provides capital to companies during follow-on financings, supporting them through pivotal growth stages.

Strategic Guidance

The firm collaborates strategically with portfolio company boards, management teams, and co-investors to facilitate successful corporate partnerships, IPOs, and trade sales.

Liquidity Solutions

Rosetta Capital offers adaptable liquidity solutions to investors and corporations through direct secondary transactions.


Portfolio

Invested in February 2023.

#Biotech and Drug Delivery

Invested in February 2023.

#Medtech

Invested in November 2022.

#Biotech

Invested in November 2022.

#Biotech

Invested in November 2022.

#Biotech

Invested in November 2022.

#Biotech

View All Portfolio Items

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.